Coral Laboratories Ltd — Results, 13-08-2025: Result

The company's board approved financial results for the quarter ended June 30, 2025, reporting a profit of ₹2.56 Cr from ₹20.87 Cr in total income. The 43rd Annual General Meeting is set for September 26. M/s. S C Mehra & Associates LLP were appointed as new statutory auditors for five years, following the Audit Committee's suggestion and succeeding M. A. Parekh & Associates, subject to shareholder vote. Importantly, the board approved altering the company's core business objectives to expand into manufacturing, trading, importing, and exporting a broader range of pharmaceutical and healthcare products for humans and animals. This strategic change also awaits shareholder approval.